1314760-71-8 Usage
Uses
Used in Organic Synthesis:
1-(4-Brom-3-Methylphenyl)cyclopropan-1-carbonitril is used as an intermediate in the synthesis of various organic compounds. Its unique structure allows for a range of chemical reactions, making it a versatile building block for the creation of new molecules with potential applications in various industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-Brom-3-Methylphenyl)cyclopropan-1-carbonitril is used as a starting material for the development of new pharmaceuticals. Its potential biological activity and chemical reactivity make it a promising candidate for the design and synthesis of novel drugs targeting various medical conditions.
Used in Chemical Research:
1-(4-Brom-3-Methylphenyl)cyclopropan-1-carbonitril is also used as a research compound in the field of chemical sciences. Its unique structure and potential reactivity make it an interesting subject for studying various chemical reactions and mechanisms, contributing to the advancement of knowledge in the field.
Used in Pharmaceutical Sciences:
In pharmaceutical sciences, 1-(4-Brom-3-Methylphenyl)cyclopropan-1-carbonitril is used for the investigation of its potential therapeutic applications. Its chemical and biological properties may lead to the discovery of new drugs or drug candidates for the treatment of various diseases and medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1314760-71-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,7,6 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1314760-71:
(9*1)+(8*3)+(7*1)+(6*4)+(5*7)+(4*6)+(3*0)+(2*7)+(1*1)=138
138 % 10 = 8
So 1314760-71-8 is a valid CAS Registry Number.
1314760-71-8Relevant academic research and scientific papers
LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPAR1) INHIBITOR COMPOUNDS
-
Page/Page column 76, (2019/03/17)
A compound of formula (I) or a pharmaceutical salt thereof, use, methods for its preparation are described.
COMPOUNDS AND THEIR METHODS OF USE
-
Page/Page column 204-205, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
